Case Report: Pneumonia Caused by Chlamydia Psittaci and Cryptococcus Co-Infection

Figures & data

Table 1 Laboratory Test Results of the Patient

Test Parameter	Reference Range	On the Day of Admission	After 2 Weeks of Treatment
WBC count (×10^9/L)	4–10	9.65	6.81
Neutrophil count (×10^9/L)	1.8–6.3	7.37	3.79
Neutrophil (%)	40–75	76.3	55.6
Lymphocyte count (×10^9/L)	1.1–3.2	1.24	2.14
Lymphocyte (%)	20–40	12.8	31.4
CRP (mg/L)	0–5	189.28	12.5
Procalcitonin (ng/mL)	0–0.05	0.09	0.07
ALT (U/L)	9–50	128	76.5
AST (U/L)	15–40	57.8	42.9
LDH (U/L)	109–245	238	254
Creatinine (μmol/L)	62–106	88.3	73.2
CK (U/L)	26–196	336	138
CK-MB (U/L)	0–25	10	10.3

Abbreviations: ALT, alanine aminotransferase; AST, aspartate aminotransferase; CK, creatine kinase; CK-MB, creatine kinase muscle isoenzyme; CRP, C-reactive protein; LDH, lactate dehydrogenase; WBC, white blood cell.

Figure 1 Chest computed tomography (CT) images of the patient. Chest CT on admission showing bilateral pneumonia (A–D). Chest CT after 2 weeks of treatment showing improvement in the bilateral pneumonia (E–H); Chest CT after 4 weeks of treatment showing complete resolution of the lung changes (I–L).